All Stories

  1. Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: an open-label, single-arm, phase 2 trial

    Article • Radiotherapy and Oncology, July 2021, Elsevier

    Xiaofei Zhu

  2. Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial

    Article • The Lancet Oncology, July 2021, Elsevier

    Xiaofei Zhu

  3. Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy

    Article • Frontiers in Oncology, June 2021, Frontiers

    Xiaofei Zhu

  4. Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles

    Article • Cancer Science, November 2020, Wiley

    Xiaofei Zhu

  5. Prognostic value of 18F-FDG PET /CT metabolic parameters in patients with locally advanced pancreatic Cancer treated with stereotactic body radiation therapy

    Article • Cancer Imaging, March 2020, Springer Science + Business Media

    Xiaofei Zhu

  6. Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications

    Article • Cancer Biology and Medicine, January 2020, Tsinghua University Press

    Xiaofei Zhu

  7. Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study

    Article • Therapeutic Advances in Medical Oncology, January 2020, SAGE Publications

    Xiaofei Zhu

  8. Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD score)

    Article • Radiotherapy and Oncology, November 2018, Elsevier

    Xiaofei Zhu

  9. Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancer

    Article • Cancer Management and Research, October 2018, Dove Medical Press

    Xiaofei Zhu

  10. Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer

    Article • Cancer Medicine, May 2018, Wiley

    Xiaofei Zhu

  11. Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matched analysis of a prospectively collected database

    Article • Cancer Management and Research, May 2018, Dove Medical Press

    Xiaofei Zhu, Wenyu Liu

  12. A modified formula for dose calculations of stereotactic ablative body radiotherapy for non–small cell lung cancer

    Article • Medical Dosimetry, January 2018, Elsevier

    Xiaofei Zhu

  13. Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer

    Article • Cancer Medicine, August 2017, Wiley

    Xiaofei Zhu